The use of auricular acupuncture in opioid use disorder: A systematic literature review

2016 ◽  
Vol 25 (8) ◽  
pp. 592-602 ◽  
Author(s):  
Tanya E. Baker ◽  
Grace Chang
2021 ◽  
Author(s):  
Erica N. Onuoha ◽  
Jared A. Leff ◽  
Bruce R. Schackman ◽  
Kathryn E. McCollister ◽  
Daniel Polsky ◽  
...  

2017 ◽  
Vol 19 (3) ◽  
pp. 259-269 ◽  

Most research designed to answer the “why” of the prescription opioid epidemic has relied on structured interviews, which rigidly attempt to capture the complex reasons people use opioids. In contrast this systematic literature review focuses on peer-reviewed studies that have used a qualitative approach to examine the development of an opioid-use disorder from the point of initial exposure. Rather than simply providing a “high,” opioids reportedly relieve psychological/emotional problems or provide an escape from life stressors. As use continues, avoidance of withdrawal sickness becomes an overriding concern, with all other benefits playing minor roles in persistent use. These studies indicate that terms used in structured interviews, such as “nontherapeutic use” or variations thereof, poorly capture the complex range of needs opioids satisfy. Both quantitative/structured studies and more qualitative ones, as well as more focused studies, have an important role in better informing prevention and treatment efforts.


2021 ◽  
pp. 1-20
Author(s):  
Ashton E. Clark ◽  
Shelby R. Goodwin ◽  
Russell M. Marks ◽  
Annabelle M. Belcher ◽  
Emily Heinlein ◽  
...  

2019 ◽  
Vol 6 ◽  
pp. S100
Author(s):  
Samah Hassan ◽  
QingPing Zheng ◽  
Erica Rizzolo ◽  
Evrim Tezcanli ◽  
Sukriti Bhardwaj ◽  
...  

2020 ◽  
Vol 10 (9) ◽  
pp. 37
Author(s):  
Suha Abdulwahab ◽  
Vahe Kehyayan ◽  
Atef Al-Tawafsheh

Background and objective: Chronic pain is a common symptom among patients worldwide. This issue leads health care professionals to manage patients’ chronic pain by using opioids. However, some patients tend to abuse these medications and develop opioid use disorder. The aim of the study was to identify and explore factors that influence nurses’ knowledge and attitudes toward patients in chronic pain with opioid use disorder.Methods: A literature review was conducted. CINAHL, Medline, and PsychINFO databases were used to search for relevant articles. A total of 12 articles that met the inclusion criteria were retrieved.Results: This literature review showed several factors that influence nurses’ knowledge and attitudes. These factors were nurses’ education, role support, demographic factors, nurses’ experiences, and nurses’ beliefs and culture.Conclusions: The findings of this literature review will inform the development of an educational program to promote nurses’ knowledge and attitudes toward patients in chronic pain with opioid use disorder.


2018 ◽  
Vol 30 (5) ◽  
pp. 136-146 ◽  
Author(s):  
Traci J. Speed ◽  
Vinay Parekh ◽  
William Coe ◽  
Denis Antoine

2020 ◽  
Author(s):  
◽  
Mary MacLellan

Stigma is a complex phenomenon with a myriad of detrimental health and social impacts that are not fully studied or understood. Persistent stigma exists towards individuals who have opioid use disorder (OUD) in British Columbia. OUD is a chronic, relapsing, clinical condition that has been identified as one of the most challenging substance use disorders. For those affected, they must also endure the consequences of stigma that promote barriers to health care, health and social inequalities, diminished quality of life as well as increased morbidity and mortality. The current unremitting opioid overdose crisis in British Columbia further emphasizes the importance of eradicating stigma towards individuals who use opioids and/or suffer from OUD, as untreated OUD is fueling this multifaceted public health emergency. For these reasons, an integrative literature review has been conducted to identify how primary care providers in British Columbia can address the intersecting stigmas for individuals suffering OUD. The results are discussed within the context of primary health care in British Columbia. Whittemore and Knafl’s approach to the integrative literature review was utilized in this study to review eleven pertinent articles. The findings suggest that stigma occurs on varying levels for individuals with OUD that serve to reinforce each other and manifest as discrimination, mistrust, social distancing, minimized advocacy, unequal access to health care and suboptimal health care. Further, the findings indicated that the role of primary care providers may be instrumental in eradicating stigma in a timely manner. Recommendations for primary care providers to dismantle the stigma associated with OUD are discussed, and specific strategies for the primary care setting are presented.


2021 ◽  
pp. 026921632110453
Author(s):  
Belinda Butcher ◽  
Elizabeth Hutchings ◽  
Belinda Fazekas ◽  
Katherine Clark ◽  
Debra Rowett ◽  
...  

Background: Standard of care in treatment of cancer-related pain involves opioids in combination with non-steroidal anti-inflammatory drugs (NSAID). Ketorolac, a NSAID, has demonstrated opioid-sparing effects in other clinical settings. Aim: This systematic literature review investigated ketorolac’s opioid-sparing effects in patients receiving opioids for chronic, cancer-related pain. Design: The primary outcome was total daily dose of opioids. Secondary outcomes included frequency of opioid use, use and frequency of ‘rescue’ medication and adverse events. Outcomes were described, and meta-analysed where possible. PROSPERO registration CRD42019130894. Data sources: Articles included original research, from any study phase or methodology, published in English in a peer-reviewed journal or conference between 1990 and 2020; included subjects >18 years; had chronic cancer-related pain and described the use of opioid-sparing effect of ketorolac. Results: Nine articles were included. While there was significant heterogeneity, ketorolac may have an opioid-sparing effect, with significant reductions in total daily dose of morphine observed in a single randomised controlled trial (SMD −4.30 mg, 95% CI −5.36 to −3.25), but the changes in the before and after studies were not statistically significant −0.46 mg (95% CI −1.14 to 0.22). Ketorolac was associated with greater likelihood of complete pain relief, but the data were heterogeneous. Insufficient data were available to analyse frequency of opioid use, or rescue medication requirements. Conclusions: Given the heterogeneity of the data, adequately powered, randomised controlled trials are required to establish any opioid-sparing effect of ketorolac. For patients not responding to conventional pain management, ketorolac may have a role in treatment augmentation.


2020 ◽  
Vol 29 (4) ◽  
pp. 249-267
Author(s):  
Breanne E. Biondi ◽  
Xiaoying Zheng ◽  
Cynthia A. Frank ◽  
Ismene Petrakis ◽  
Sandra A. Springer

Sign in / Sign up

Export Citation Format

Share Document